Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastoma.
Matthijs van der MeulenRonald C RamosMathew R VoisinVikas PatilQingxia WeiOlivia SinghSeth A ClimansNavya KalidindiRosemarylin OrKen AldapePhedias DiamandisDavid G MunozGelareh ZadehWarren P MasonPublished in: Neuro-oncology advances (2024)
A small group of patients with IDH-wild-type GBM survive more than 5 years. While there are few differences in the global methylation profiles of LTS compared to STS, our study highlights potential pathways involved in GBMs with a good or poor prognosis.